Clofazimine-induced skin pigmentation
Ashwin Karnan, Anjana Ledwani
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLeprosy Research and Treatment · Acne and Rosacea Treatments and Effects · Plant-based Medicinal Research
Image in medicine
A 54-year-old male presented to the outpatient department with complaints of black discoloration of skin and nails for the past 1 month. The patient gave a history of multi-drug resistant sputum positive tuberculosis for which he is on antitubercular drugs (Isoniazid, Ethambutol, Pyrazinamide, Clofazimine, Bedaquiline, Levofloxacin, and Ethionamide) for the past 9 months. A dermoscopy was done which showed yellow globules in a honeycombing pattern and hyperpigmentation with sparing of the sweat glands. A diagnosis of Clofazimine-induced hyperpigmentation was made. As a physician, with tuberculosis nearing elimination, monitoring and managing the adverse effects of drugs is important. Clofazimine is a riminophenazine dye that has both anti-microbial and anti-inflammatory action. It is absorbed orally and is known to accumulate in tissues. It has a very long half-life of about 70 days and is excreted in small amounts in bile, urine, and sweat. It is used in leprosy, multidrug-resistant tuberculosis, lepra reaction, and in other mycobacterial infections. Clofazimine-induced pigmentation is reversible but takes months to years to clear after stopping the drug.
generalized hyperpigmentation over the face